期刊文献+

研究鉴别原发性肺腺癌与转移性肺肿瘤的一组免疫组化标志物 被引量:3

The Expressions of Immunohistochemical Markers in Discriminating between Primary Adenocarcinomas and Lung Metastatic Tumors
下载PDF
导出
摘要 目的:探讨原发性肺腺癌和转移性肺肿瘤中天门冬氨酸蛋白酶(Napsin A)、肺表面活性物质相关蛋白A(SP-A)、甲状腺转移因子-1(TTF-1)临床病理学意义。方法:用免疫组化技术Super PicTureTM Polymer二步法检测Napsin A、SP-A、TTF-1在76例原发性非小细胞肺癌和40例转移性肺肿瘤中的表达水平。结果:Napsin A与原发性肺腺癌的分化程度呈正相关(P<0.05)。Napsin A、SP-A和TTF-1在原发性非小细胞肺癌中的阳性表达与其分型密切相关(均P<0.05)。Napsin A比SP-A、TTF-1具有较高的敏感性和特异性。结论:Napsin A是原发性肺腺癌发生发展过程中较早出现的一种较为敏感的肿瘤标志物,其表达强度与肿瘤的恶性程度密切相关,而且联合使用SP-A、TTF-1有助于鉴别原发性肺腺癌与转移性肺肿瘤。 Objective: To evaluate the utility of novel aspartic proteinase A (Napsin A), pulmonary surfatcant-associated protein (SP-A) and thyroid transcription factor-1 (TTF-1)immunostaining in the discrimination between primary adenocarcinomas and lung metastatic tumors. Methods: The expressions of Napsin A, SP- A and TFF-1 were detected in 76 patients with primary non-small cell lung cancer and 40 with metastatic tumors by immunohistochemical Super Pic TureTM Polymer method. Results: It was showed that Napsin A was associated with the differentiation grade of adenocarcinoma (P 〈 0.05). The expressions of Napsin A,SP- A and TTF-1 were significantly related with types of primary non-small cell lung cancer (P 〈 0.05). It was found that Napsin A had a higher sensitivity and specificity than those of SP-A and TTF-1. Conclusion: The results suggested that Napsin A was expressed in a large proportion of primary lung adenocarcinomas and was associated with the differentiation grade of adenocarcinoma. It was helpful in discriminating between primary adenocarcinomas and lung metastatic tumors by combining SP-A and TTF-1.
作者 王菁 徐美林
出处 《天津医药》 CAS 北大核心 2009年第3期189-191,I0002,共4页 Tianjin Medical Journal
关键词 天冬氨酸内肽酶类 肺表面活性物质相关蛋白质A 腺癌 肺肿瘤 肿瘤转移 免疫组织化学 aspartic endopeptidases pulmonary surfactant-associated protein A adenocarcinoma lung neoplasms neoplasm metastasis immunohistochemistry
  • 相关文献

参考文献7

  • 1郭峰,卢兆桐,邹志强.原发性肺腺癌肿瘤标记物Napsin A的研究现状[J].国外医学(肿瘤学分册),2005,32(5):388-391. 被引量:4
  • 2Ueno T,Linder S,Na CL,et al.Processing of pulmonary surfactant protein B by napsin and cathepsin H [J].J Biol Chem,2004,279 (16) : 16178-16184.
  • 3Crouch E, Wright JR.Surfaetant proteins A and D and pulmonary host defense[J].Annu Rev Physiol, 2001,63 : 521-554.
  • 4Ordonez NG.Value of thyoid transcription factor-1 in distinguishing small cell lung carcinomars from other small carcinomars [J].Am J Surg Pathol, 2000,24(9) : 1217-1223.
  • 5Ueno T,Linder S,Elmberger G.Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinomas [J].Br J Cancer,2003,88(8): 1229-1233.
  • 6熊焰,徐钢.具有Ⅱ型肺泡上皮细胞分化肿瘤的临床病理特点[J].实用医院临床杂志,2006,3(2):86-87. 被引量:1
  • 7Hirano T,Auer G,Maeda M, et al.Human tissue distribution of TA02, which is homologous with a new type of aspartic proteinase, napsin A[J].Jpn J Cancer Res,2000,91(10):1015-1021.

二级参考文献42

  • 1[4]Yousem SA,Hochholzer L.Alveolar adenoma[J].Hum Pathol,1986,17(10):1066-1071.
  • 2[5]Hartman MS,Epstein DM,Geyer SJ,et al.Alveolar adenoma[J].Ann Thorac Surg,2004,78(5):1842-1843.
  • 3[6]Fujimoto K,Muller NL,Sadohara J,et al.Alveolar adenoma of the lu-ng:computed tomography and magnetic resonance imaging findings[J].J Thorac Imaging,2002,17(2):163-166.
  • 4[7]Cavazza A,Paci M,De Marcol,et al.Alveolar adenoma of the lung:a clinicopathologic,immunohistochemical,and molecular study of an unusual case[J].Int J Surg Pathol,2004,12(2):155-159.
  • 5[8]Papla B,Malinowski E.Alveolar adenoma of the lung-a report of two case[J].Pol J Pathol,2003,54(2):147-152.
  • 6[9]Fantone JC,Geisinger KR,Appelman HD.Papillary adenoma of the lung with lamellar and electron dense granules[J].Cancer,1982,50(12):2839-2844.
  • 7[10]Minami Y,Morishita Y,Yamamoto T,et al.Cytologic characteristics of pulmonary papillary adenoma A case report[J].Acta Cytol,2004,48(2):243-248.
  • 8[11]Liebow AA,Hubbell DS.Sclerosing hemangioma(histocytoma,xanth-oma)of the lung[J].Cancer,1956,9(1):53-75.
  • 9[13]Niho S,Suzuki K,Yokose T,et al.Monoclonality of both pale cells and cuboidal cells of sclerosing hemangioma of the lung[J].Am J Pathol,1998,152(4):1065-1069.
  • 10[14]Kay S,Still WJ,Borochovitz D.Sclerosing hemangioma of the lung:an endothelial or epithelial neoplasm[J].Hum Pathol,1997,8:468.

共引文献3

同被引文献30

  • 1郭峰,卢兆桐,邹志强.原发性肺腺癌肿瘤标记物Napsin A的研究现状[J].国外医学(肿瘤学分册),2005,32(5):388-391. 被引量:4
  • 2周庚寅,翟启辉,张庆慧.诊断免疫组织化学[M].2版.北京:北京大学医学出版社,2008:452.
  • 3孟宇宏,张建中,译.肺、胸膜、胸腺及心脏肿瘤病理学和遗传学[M].北京:人民卫生出版社,2006:110-111.
  • 4Ueno T, Linder S, Elmberger G. Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinoma[J]. Br J Cancer,2003,88(8) :1229- 1233.
  • 5Hirano T, Gong Y, Yoshida K, et al. Usefulness of TA02 (napsin A) to distinguish primary lung adenocarcinoma from metastatic lung adenocarcinoma[J]. Lung Cancer, 2003,41 (2) : 155-162.
  • 6Tatnell P J, Powell D J, Hill J, et al. Napsins= new human aspartic proteinases. Distinction between two closely related genes[J]. FEBS Lett,1998,441(1) :43-48.
  • 7Sandier A, Hirsh V,Reck M, et al. An evidence based review of the incidence of CNS bleeding with anti-VEGF therapy in nons- mall cell lung cancer patients with brain metastases[J]. Lung Cancer,2012,78(1) :1.
  • 8Khayyata S,Yun SJ Pasha T et al. Value of P63 and CK5/6 in dis- tinguishing squamous cell carcinoma a from adenocarcinoma in lung fine-needle aspiration specimens[J]. Dign Cytopathol, 2009, 37(3) :178.
  • 9Khayyata S,Yun S,Pasha T,et al. Value of p63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens[J]. Dign Cytopathol, 2009, 37(3) :178.
  • 10Terry J, Leung S, Laskin J, et al. Optimal immunohisto chemical markeYs for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples[J]. Am J Surg Pathol, 2010,34(12) :1805.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部